What is the recommended dose and frequency for administering Haloperidol (Haldol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Haloperidol Dosing and Frequency

For acute agitation in adults, start with 5-10 mg orally or intramuscularly, repeatable every 30-60 minutes as needed, with a maximum daily dose of 40 mg; however, for elderly patients (≥65 years), initiate with 0.5-1 mg and do not exceed 5 mg daily. 1, 2

Adult Dosing (Non-Elderly)

Initial Dose

  • Standard starting dose: 5-10 mg (oral or intramuscular) 1, 2
  • For severe agitation or immediate danger: Consider 10-20 mg for rapid tranquilization 1, 2
  • Can use higher initial dose (1.5-3 mg) if severely distressed 1

Frequency and Repeat Dosing

  • Repeat every 30-60 minutes as needed for ongoing agitation 1, 2
  • For severe cases: May repeat every 20-30 minutes until controlled 1, 2
  • Maximum daily dose: 40 mg 1, 2

Pharmacokinetics to Guide Timing

  • Onset: 20-30 minutes (oral), 10-20 minutes (IM), 5-15 minutes (IV) 1, 2
  • Peak effect: 4-5 hours (oral), 60 minutes (IM), 20 minutes (IV) 1, 2
  • Duration: 6-8 hours (oral), up to 24 hours (IM) 1, 2

Elderly Patients (≥65 Years) - Critical Dose Reduction Required

Initial Dose

  • Start with 0.5-1 mg orally OR 0.25-0.5 mg intramuscularly 1, 3
  • Preferably administer at night 3

Frequency and Repeat Dosing

  • Repeat every 1-2 hours as needed for IM route 3
  • Repeat every 2 hours as needed for oral route 1, 3
  • Increase in 0.5-1 mg increments only if necessary 1
  • Maximum daily dose: 5 mg (not 40 mg as in younger adults) 1, 3

Evidence Supporting Low-Dose Approach in Elderly

  • Higher doses show no benefit in decreasing agitation duration but significantly increase sedation risk 3
  • Low-dose haloperidol results in shorter hospital stays, less restraint use, and better discharge outcomes 3, 4, 5
  • In a 2023 study, elderly patients receiving ≤0.5 mg required no additional doses within 4 hours and had better outcomes than higher-dose groups 4

Pediatric Dosing

Children (6-12 years)

  • Initial dose: 0.5-2 mg or 2.5 mg 1, 2
  • Weight-based: 0.05-0.1 mg/kg (oral/IM) 1
  • Maximum daily dose: 30 mg 1, 2

Adolescents (12-16 years)

  • Initial dose: 10 mg 1, 2
  • May repeat every 2 hours as needed 1

Older Adolescents (>16 years)

  • Initial dose: 5-10 mg 1, 2
  • Maximum daily dose: 40 mg 1, 2

For Acute Agitation in Pediatrics

  • 0.05-0.15 mg/kg IV/IM, maximum 5 mg per dose 2, 6
  • May repeat hourly as needed 2, 6

Special Clinical Contexts

Delirium Management

  • Able to swallow: 0.5-1 mg orally at night and every 2 hours PRN 1
  • Increase in 0.5-1 mg increments as required 1
  • Maximum: 10 mg daily (5 mg daily in elderly) 1
  • Unable to swallow: Consider levomepromazine instead (12.5-25 mg subcutaneously) 1

Palliative Care/End-of-Life

  • Start with 0.5-1 mg PO or subcutaneously 2
  • PRN dosing: 0.5-1 mg every hour as needed 2
  • Use lower doses (0.25-0.5 mg) for older or frail patients 2

First-Episode Psychosis

  • Start with 2 mg daily - many patients respond to this low dose 7, 8
  • Increase weekly to 5 mg, then 10 mg, then 20 mg only if inadequate response 7
  • Optimal plasma levels typically below 5 ng/mL 7
  • Low dose (2 mg) equally effective as high dose (8 mg) but better tolerated 8

Critical Monitoring and Safety Considerations

Extrapyramidal Symptoms (EPS)

  • Higher doses significantly increase EPS risk 1, 9
  • Doses >7.5 mg/day have substantially higher EPS rates compared to 3-7.5 mg/day 9
  • If EPS develop, reduce next dose 2
  • Consider adding benzodiazepine rather than increasing haloperidol 1

QTc Prolongation Risk

  • Risk increases with doses above 7.5 mg/day 2
  • Monitor ECG with repeated doses 2

When NOT to Use Haloperidol

  • Intoxication-related agitation: Use benzodiazepines first-line 1, 2
  • Severe neutropenia (ANC <1000/mm³): Discontinue 10
  • Severe cardiovascular disorders: Use cautiously due to hypotension risk 10

Combination Therapy

  • For severe agitation unresponsive to haloperidol alone: Add benzodiazepine (lorazepam 0.5-1 mg or midazolam 2.5-5 mg) rather than escalating haloperidol dose 1, 2
  • Older adolescents (>16 years): Haloperidol + lorazepam or midazolam is recommended combination 1

Common Pitfalls to Avoid

  1. Overdosing elderly patients: The 40 mg maximum applies to adults, NOT elderly patients (5 mg max) 1, 3
  2. Using depot formulations acutely: Depot haloperidol is NOT for acute agitation - requires 12 months of stability first 6
  3. Escalating doses unnecessarily: Evidence shows doses >7.5 mg/day offer no additional efficacy but increase adverse effects 9, 5
  4. Ignoring non-pharmacological interventions first: Especially in elderly, attempt orientation, adequate lighting, and communication before medication 1, 3
  5. Using haloperidol for substance-induced agitation: Benzodiazepines are preferred 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Haloperidol Dosage and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Haloperidol Dosage in Elderly Patients with Psychomotor Agitation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Early Administration of Haloperidol Depot

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Optimal haloperidol dosage in first-episode psychosis.

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1999

Research

Haloperidol dose for the acute phase of schizophrenia.

The Cochrane database of systematic reviews, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.